![](/img/cover-not-exists.png)
Phase I study of MN-001, an oral anti-inflammatory agent for the treatment of asthma
Locke, K.W.Volume:
115
Language:
english
Journal:
Journal of Allergy and Clinical Immunology
DOI:
10.1016/j.jaci.2004.12.616
Date:
February, 2005
File:
PDF, 30 KB
english, 2005